I-DXD: clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
3
Conditions studied
12
US states with sites
14
Countries
Phase breakdown
Phase 1 1
Phase 2 2
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Lung Neoplasm | 1 |
| Small Cell Lung Cancer Extensive Stage | 1 |
Recruiting trials involving I-DXD
- A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
- Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Common questions
How many recruiting trials involve I-DXD?
2 recruiting trials across 3 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.